Maderis stepping down from Five Prime – St. Louis Business Journal:

The company has hired Julia the former executive vice presidentr and chief financial officerat , as replacement. Maderis’ health conditio n was not disclosed, but she will continue to serve onFive Prime’es board of directors and as a consultant. Her finap day on the job is June 18. “Gail’s leadershi p has been pivotal in the progrese Five Prime has made in developing our pipelinde and our newdiscovery platform,” said company foundert and executive chairman Dr. Lewis “Rusty” Williams in a presss release.
Maderis said the company had been lookingg for a replacement since late last year after doctorssaid "thre 24/7 pace of a small-companyh CEO" could worsen her condition. Besides her dutiesd at Five Prime, Maderis has been a cheerleader for the MissionbBay enclave, serving on the Mayor’s . Five a privately held, 7-year-old company developing antibody and proteim drugs for cancer andothetr diseases, was the first to locate in Missiob Bay, taking about 30,000 feet in the building on Owens Earlier this year, it took an additional 5,000 square feet next door at 1700 Owens as it makesd batches for its Phase I oncology drug program.
The timingb of the executive change as Five Primes moves forward with its lead cancefr programmakes Gregory’s appointment a crucial one. At Gregory was responsible forfinancing strategies, merger s and acquisitions, business operations and all financial management and accounting. She raised about $1 billion in public and private equity, product development financing andother Gregory, who will join Five Prime’ss board, was an investment banke r for more than 20 years. At and Dillon, Read & Co. Inc. she was head of healthcarr andinvestment banking, leading several private and publixc equity deals as well as mergerws and acquisitions.
Gregory also is a membet of the board of The andthe ’ .
livejournal.com